Singh Shivendra V, Varma Vijayalakshmi, Zimniak Piotr, Srivastava Sanjay K, Marynowski Stanley W, Desai Dhimant, Amin Shantu, Ji Xinhua
Department of Pharmacology and University of Pittsburgh Cancer Institute, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15213, USA.
Biochemistry. 2004 Aug 3;43(30):9708-15. doi: 10.1021/bi049435f.
The ultimate diol epoxide carcinogens derived from polycyclic aromatic hydrocarbons, such as benzo[a]pyrene (BP), are metabolized primarily by glutathione (GSH) conjugation reaction catalyzed by GSH transferases (GSTs). In human liver and probably lung, the alpha class GSTs are likely to be responsible for the majority of this reaction because of their high abundance. The catalytic efficiency for GSH conjugation of the carcinogenic (+)-anti-benzo[a]pyrene-7,8-diol-9,10-epoxide [(+)-anti-BPDE] is more than 5-fold higher for hGSTA1-1 than for hGSTA2-2. Here, we demonstrate that mutation of isoleucine-11 of hGSTA2-2, a residue located in the hydrophobic substrate-binding site (H-site) of the enzyme, to alanine (which is present in the same position in hGSTA1-1) results in about a 7-fold increase in catalytic efficiency for (+)-anti-BPDE-GSH conjugation. Thus, a single amino acid substitution is sufficient to convert hGSTA2-2 to a protein that matches hGSTA1-1 in its catalytic efficiency. The increased catalytic efficiency of hGSTA2/I11A is accompanied by greater enantioselectivity for the carcinogenic (+)-anti-BPDE over (-)-anti-BPDE. Further remodeling of the H-site of hGSTA2-2 to resemble that of hGSTA1-1 (S9F, I11A, F110V, and S215A mutations, SIFS mutant) results in an enzyme whose catalytic efficiency is approximately 13.5-fold higher than that of the wild-type hGSTA2-2, and about 2.5-fold higher than that of the wild-type hGSTA1-1. The increased activity upon mutations can be rationalized by the interactions of the amino acid side chains with the substrate and the orientation of the substrate in the active site, as visualized by molecular modeling. Interestingly, the catalytic efficiency of hGSTA2-2 toward (-)-anti-BPDE was increased to a level close to that of hGSTA1-1 upon F110V, not I11A, mutation. Similar to (+)-anti-BPDE, however, the SIFS mutant was the most efficient enzyme for GSH conjugation of (-)-anti-BPDE.
多环芳烃衍生的最终二醇环氧化物致癌物,如苯并[a]芘(BP),主要通过谷胱甘肽S-转移酶(GSTs)催化的谷胱甘肽(GSH)结合反应进行代谢。在人肝脏以及可能在肺中,α类GSTs可能由于其高丰度而负责大部分此类反应。致癌性(+)-反式苯并[a]芘-7,8-二醇-9,10-环氧化物[(+)-反式BPDE]与GSH结合的催化效率,hGSTA1-1比hGSTA2-2高5倍以上。在此,我们证明hGSTA2-2的异亮氨酸-11(该残基位于酶的疏水底物结合位点(H位点))突变为丙氨酸(hGSTA1-1中相同位置存在的氨基酸),导致(+)-反式BPDE-GSH结合的催化效率提高约7倍。因此,单个氨基酸取代足以将hGSTA2-2转化为催化效率与hGSTA1-1相当的蛋白质。hGSTA2/I11A催化效率的提高伴随着对致癌性(+)-反式BPDE相对于(-)-反式BPDE更高的对映体选择性。对hGSTA2-2的H位点进行进一步重塑使其类似于hGSTA1-1(S9F、I11A、F110V和S215A突变,SIFS突变体),得到一种酶,其催化效率比野生型hGSTA2-2高约13.5倍,比野生型hGSTA1-1高约2.5倍。通过分子模拟可视化,突变后活性增加可通过氨基酸侧链与底物的相互作用以及底物在活性位点的取向来解释。有趣的是,F110V而非I11A突变后,hGSTA2-2对(-)-反式BPDE的催化效率提高到接近hGSTA1-1的水平。然而,与(+)-反式BPDE类似,SIFS突变体是(-)-反式BPDE与GSH结合的最有效酶。